Sanofi India Limited
SANOFI · NSE · ₹3,037 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Sanofi India Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 7.7%; Net profit was ₹83.50 crore.
Quarter ended 2026-06-30 · standalone · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹438 cr | +7.7% | Net profit: ₹84 cr | +20.1% | 19.1% | Company filing source |
| Mar 2026 | Revenue: ₹472 cr | -11.9% | Net profit: ₹103 cr | -14.1% | 21.7% | Company filing source |
| Dec 2025 | Revenue: ₹420 cr | — | Net profit: ₹62 cr | — | 14.7% | Company filing source |
| Sep 2025 | Revenue: ₹475 cr | — | Net profit: ₹76 cr | — | 16.0% | Company filing source |
| Jun 2025 | Revenue: ₹406 cr | — | Net profit: ₹70 cr | — | 17.1% | Company filing source |
| Mar 2025 | Revenue: ₹536 cr | — | Net profit: ₹120 cr | — | 22.3% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
HOECHST GMBH 60.4%LIFE INSURANCE CORPORATION OF INDIA - P & GS Fund 6.0%NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND 4.1%GENERAL INSURANCE CORPORATION OF INDIA 2.6%ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C - ADITYA BIRLA SUN LIFE MNC FUND 2.3%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company. Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requir…
29 Sep 2026 · document
- Disclosure under SEBI Takeover Regulations. Sanofi Healthcare India Private Limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-R…
28 Sep 2026 · document
- Updates. Sanofi India Limited has informed the Exchange regarding Disclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI…
28 Sep 2026 · document
- Updates. Sanofi India Limited has informed the Exchange regarding 'Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations,…
28 Sep 2026 · document
- Action(s) taken or orders passed. Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show…
25 Sep 2026 · document
- Sanofi India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
25 Sep 2026 · document
- Action(s) taken or orders passed. Disclosure Under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)…
21 Sep 2026 · document
- Disclosure under SEBI Takeover Regulations. Sanofi Healthcare India Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) o…
17 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time